Adolescent girls and those with co-morbidities were at a higher risk of adverse events after receiving Bharat Biotech’s BBV152 (Covaxin) vaccine against COVID-19, BHU researchers said. New onset skin and subcutaneous disorders, general disorders, and nervous system disorders were the common AESIs in adolescents. General disorders, musculoskeletal disorders, and nervous system disorders were the common AESIs in adults. Neither the ICMR nor the company had published the long-term safety trials, it charged. While using telephonic interviews was not ideal, it has been used by ICMR in the past, even in papers on COVID vaccines.

Source: The Hindu May 26, 2024 09:57 UTC